Celyad VP On IP Issues, Development Timelines For CAR-T Therapies

 
• By Lucie Ellis-Taitt

Georges Rawadi, vice president of business development and intellectual property at Celyad, talks to Scrip on the sidelines of the recent BIO-Europe Spring partnering conference in Barcelona about the company's pipeline of CAR-T therapies and recently resolved patent disputes for its technology.

Video interview
Celyad's George Rawadi talks to Scrip

More from Start-Ups & SMEs

More from Business